Herein, we focused on the P210BCR-ABL fusion gene (including two subtypes, b3a2 and b2a2), which is the most common type in patients with CML and is shared by some patients with acute lymphoblastic leukemia (ALL)[25]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.